Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
12
NMPA:12
Drug Approvals
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
Phase 2
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Drug: ND-L02-s0201 (Low Dose)Drug: ND-L02-s0201 (High Dose)
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- Nitto Denko Corporation
- Target Recruit Count
- 123
- Registration Number
- NCT03538301
- Locations
- 🇺🇸
Banner-University Medical Center Tucson Campus, Tucson, Arizona, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Amicis Research Center, Northridge, California, United States
Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Influenza
- First Posted Date
- 2016-11-04
- Last Posted Date
- 2017-09-18
- Lead Sponsor
- Nitto Denko Corporation
- Target Recruit Count
- 90
- Registration Number
- NCT02955030
- Locations
- 🇯🇵
OPHAC Hospital, Osaka, Japan
News
No news found